Position in AMGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,775,649
-$38,095 QoQ
Shares Held
7,665
-4.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#46
of 186 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 82.98760600130464.ToString("F0")%
Shared 0.ToString("F0")%
None 17.01239399869537.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $55,949,166 across 10 Drug Manufacturers - General names. AMGN ranks #7 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,360 | $17,223,816 | |
| 2 | JNJ |
Johnson & Johnson
|
43,755 | $11,112,457 | |
| 3 | MRK |
Merck & Co., Inc.
|
72,515 | $9,318,177 | |
| 4 | ABBV |
AbbVie Inc.
|
23,832 | $5,997,084 | |
| 5 | GRFS |
Grifols SA
|
592,173 | $4,192,584 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
28,507 | $3,601,574 | |
| 7 | AMGN |
Amgen Inc
This page
|
7,665 | $2,775,649 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
18,045 | $1,039,752 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,775,649 | 7,665 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,813,744 | 7,997 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,589,349 | 7,911 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,185,920 | 7,746 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,922,918 | 6,887 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,744,132 | 8,808 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,756,789 | 10,577 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,512,411 | 10,901 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $3,544,432 | 11,344 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,310,053 | 11,642 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,440,681 | 8,474 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,677,599 | 6,242 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,698,230 | 7,649 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,907,649 | 7,891 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,244,784 | 8,547 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $2,369,404 | 10,512 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,413,499 | 14,030 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $3,162,280 | 13,077 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $2,686,366 | 11,941 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,543,081 | 11,959 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,682,225 | 11,004 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,607,312 | 6,460 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||